Laurent Chardonnet

PRLD

Laurent Chardonnet serves as Chief Financial Officer at Prelude Therapeutics Incorporated (PRLD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$117.4K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$117.4K

Companies Traded

PRLD

Active Period

Jun 2022 – May 2023

3 total trades

Most Recent

Buy PRLD

May 25, 2023 · $27.5K

Laurent Chardonnet's Insider Trading at Prelude Therapeutics Incorporated (PRLD)

Buys

3 · $117.4K

Sells

0 · $0.00

Total Shares Bought

25,000

Total Shares Sold

PRLD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 25, 2023	Buy	5,000	$5.50	$27.5K	42,165
Dec 12, 2022	Buy	10,000	$4.76	$47.6K	35,873
Jun 1, 2022	Buy	10,000	$4.23	$42.3K	24,500

Related Insiders

David P Bonita

director, 10 percent owner:

PRLDBuy · Apr 23, 2026

ORBIMED ADVISORS LLC

director, 10 percent owner:

PRLDBuy · Apr 23, 2026

BAKER BROS. ADVISORS LP

director, 10 percent owner:

PRLDBuy · Apr 22, 2026

Jane Huang

President, CMO

PRLDSell · Oct 4, 2025

Explore More Insider Trading Data

PRLD Insider Trading Activity

View all insider trades at Prelude Therapeutics Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity